Ultragenyx Pharmaceutical (RARE) Gross Profit (2018 - 2026)
Ultragenyx Pharmaceutical's Gross Profit came in at $180 million for Q2 2026, up 25.0% from $144 million a year earlier and up 69.8% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Gross Profit (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ultragenyx Pharmaceutical reported Gross Profit of $595.88 million, up 14.6% year-over-year; for FY2025, it was $564 million, up 16.8% from FY2024.
- Gross Profit has increased in each of the last three years, with a five-year compound annual growth rate of 16.3% (FY2020 to FY2025).
- Going back by year, Gross Profit was $483 million in FY2024 (+24.2%), $389 million in FY2023 (+16.1%), $335.01 million in FY2022 (-0.1%) and $335.4 million in FY2021 (+26.6%).
- The Q2 2026 figure represents the highest quarterly Gross Profit in data going back to Q1 2018.
- Year-over-year, Gross Profit increased in seven of the last eight quarters, with growth averaging 19.0%.
- The fastest year-over-year change in Gross Profit over five years came in Q3 2024 (growth of 36.1%), and the weakest in Q1 2022 (a decline of 21.6%).
- Business Quant data shows RARE's Gross Profit at $106 million (Q1 2026), $177.93 million (Q4 2025) and $131.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.45 Bn | -348.90 Mn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 180.00 Mn |
| Mar 31, 2026 | 106.00 Mn |
| Dec 31, 2025 | 177.93 Mn |
| Sep 30, 2025 | 131.94 Mn |
| Jun 30, 2025 | 144.00 Mn |
| Mar 31, 2025 | 110.00 Mn |
| Dec 31, 2024 | 147.48 Mn |
| Sep 30, 2024 | 118.47 Mn |
| Jun 30, 2024 | 125.75 Mn |
| Mar 31, 2024 | 91.30 Mn |
| Dec 31, 2023 | 115.30 Mn |
| Sep 30, 2023 | 87.07 Mn |
| Jun 30, 2023 | 98.40 Mn |
| Mar 31, 2023 | 88.24 Mn |
| Dec 31, 2022 | 98.03 Mn |
| Sep 30, 2022 | 82.07 Mn |
| Jun 30, 2022 | 81.07 Mn |
| Mar 31, 2022 | 73.84 Mn |
| Dec 31, 2021 | 79.88 Mn |
| Sep 30, 2021 | 77.47 Mn |
API Access
Ultragenyx Pharmaceutical Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();